Why the study?
Does insulin treatment prevent alterations in cardiac parasympathetic innervation in rats with STZ-induced diabetes mellitus?
Does insulin treatment prevent alterations in cardiac parasympathetic innervation in rats with STZ-induced diabetes mellitus?
STZ-induced diabetes in rats causes biochemical and morphological alterations in cardiac parasympathetic innervation, which can be prevented by insulin treatment.
Answers are grounded in this paper and cite their sources.
Insulin may mitigate cardiac parasympathetic changes in diabetic rats; leaves open applicability to human autonomic neuropathy.
Autonomic neuropathy involving parasympathetic innervation is a complication of diabetes mellitus. Biochemical and morphological indices of the parasympathetic innervation of the heart were investigated in rats after diabetes mellitus was induced with streptozocin (STZ). Choline acetyltransferase (CAT) activity was used as a biochemical marker for parasympathetic innervation. Total CAT activity within the hearts of diabetic rats was unchanged after 1 and 2 wk of diabetes and was significantly reduced after 4, 8, and 12 wk. Morphological changes within the cardiac portion of the parasympathetic innervation were assessed at 8 wk when CAT activity was decreased. In diabetic rats, there was a reduction in both cardiac ganglion cell size and number. In contrast, in insulin-treated STZ-induced diabetic rats, ganglion cells were similar in size and number to those in a control group given 3-O-methylglucose to prevent induction of diabetes mellitus by STZ. Thus, diabetes mellitus is associated with alterations in cardiac parasympathetic innervation in rats, and supplemental insulin protects against these changes. These alterations may contribute to impaired parasympathetic neural control of the heart in diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Lund et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: